|
|
|
| 1983–1988 | 1988–2009 | 2009–2020 |
Zantac was a brand name of the drug ranitidine sold from 1983 to 2020 by multiple pharmaceutical companies throughout its existence. In 2019, recalls for Zantac began following the discovery of a cancer-causing chemical in the drug. In April 2020, the United States Food and Drug Administration issued a full market withdrawal of Zantac and other similar drugs.
1983–1988[]
|
BETTER LOGO NEEDED |
1988–2009[]
2009–2020[]
|
|
BETTER LOGO NEEDED |
Following the 2020 discontinuation of the drug, Sanofi began selling famotidine under the brand name Zantac 360°.
|
|
Zantac |
|
| Predecessors: Sanofi-Synthélabo | Aventis (Hoechst | Rhône-Poulenc)
Subsidiaries: Sanofi Pasteur | Sanofi Genzyme | Chattem | Medley | Opella Current brands: Former/defunct brands:  |
| J&J Innovative Medicine Subsidiaries: Actelion | ALZA Corporation | Cilag | Crucell | J&J Pharmaceutical Research and Development | Ortho-McNeil Pharmaceutical | Tibotec J&J MedTech Former assets: 1Johnson & Johnson retained 9.5% shares in Kenvue, its former consumer health unit.  |
| Oral health brands: Aquafresh | Binaca | Biotene | Corsodyl | Dr. Best | Iodosan | Macleans | Odol | Odol-Med3 | Parodontax | Polident | Poligrip | Pronamel | Sensodyne Respiratory brands: Pain relief brands: Nutrition and digestive health brands: Skincare brands: Other brands: Former/defunct brands:  |
| Predecessors Warner-Lambert (Parke-Davis) | Pharmacia & Upjohn (Pharmacia (G.D. Searle) | Upjohn) | Wyeth (American Home Products | A. H. Robins Company) Pharmaceuticals products Former brands and companies Divested Discontinued or defunct  |
| Subsidiaries:
Predecessors:  |